Community/Retail

A low sodium-DASH diet combination lowers blood pressure (BP) in adults with hypertension, according to the results of preliminary research at the American Heart Association’s (AHA) Scientific Sessions 2017.

Officials with the FDA have approved an adjuvanted hepatitis B vaccine, recombinant [Heplisav-B, Dynavax] for the prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Canagliflozin (Invokana, Janssen) improved renal outcomes and demonstrated potential renal protective effects, according to additional analyses from the CANVAS clinical trial presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.

Officials with the FDA have extended the approval of vemurafenib (Zelboraf, Genentech) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare blood cancer, making it the first approved treatment for ECD.